The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended. clinical trials
7 indexed studies · 0 currently recruiting
- CompletedPhase I
Phase I Trial: Quotient Code QSC302899
This is a very early-stage study, called a Phase I trial, looking into a new treatment marked as QSC302899. At the moment, the main details about who can join and what the study involves are not publicly available.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase 1 Trial: Quotient Code QSC303303, Sponsor Code LMNL6511C1002
This is an early-stage study (Phase 1) looking into a new treatment called QSC303303. The main goal is to check its safety in people aged 18 to 65. More details about this trial will be shared within 30 months after it finishes.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Study: Quotient Code QSC303166
This early-stage study, called QSC303166, is looking at a new treatment. We don't have all the details publicly yet, but it's a first step to see how safe and effective it might be. More information will be shared within 30 months after the study finishes.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Trial: Quotient Code QSC303217
This early-stage study, called Quotient Code QSC303217, is looking at a new treatment. We don't have all the details yet because the information will be shared within 30 months after the study finishes. It's for adults aged 18 to 65, including both men and women.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Study: Quotient Code QSC300759
This early-stage study is looking at a new medicine called QSC300759 in adults aged 18 to 55. For now, specific details about what this medicine is for and how the study will be run are not available, but they will be shared later.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - RecruitingPhase I
Phase I Study: Quotient Code QSC303294
This early-stage study is looking for healthy volunteers aged 18-55 to test a new medicine (QSC303294). This is a Phase 1 trial, meaning we're checking its safety and how it works in the body for the first time. More details will be shared later.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England - CompletedPhase I
Phase I Trial: Quotient Code QSC303299
This early-stage study, called Phase I: Quotient Code QSC303299, is testing a new treatment. We don't have many details yet, as they will be shared within 30 months after the study finishes. It's for men aged 30 to 65 years old. More information will become available later.
For: The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.United Kingdom · England